Reuters -
22 January 2018, 14:46 (+ 2304 days 1 hours and 13 minutes) Health
LONDON (Reuters) - Sanofi is placing a big bet on the $10 billion-a-year hemophilia market at a testing time, as scientific advances overhaul traditional approaches to treating the rare uncontrolled bleeding disorder.